Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Melanie J. DaviesDavid A. D’AlessioJohn B. Buse Consensus Report 05 October 2018 Pages: 2461 - 2498
Fifty years of pancreatic islet pathology in human type 1 diabetes: insights gained and progress made Noel G. MorganSarah J. Richardson Review Open access 25 September 2018 Pages: 2499 - 2506
Gestational weight gain: an ounce of prevention is still worth a pound of cure Patrick Catalano Commentary 15 October 2018 Pages: 2507 - 2511
Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach Abass AlaviThomas J. Werner Commentary 29 June 2018 Pages: 2512 - 2515
Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer Martin GotthardtDecio L. EizirikMaarten Brom Commentary Open access 03 October 2018 Pages: 2516 - 2519
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin Maggie H. ShepherdBeverley M. Shieldsfor the UNITED study Article Open access 18 September 2018 Pages: 2520 - 2527
The impact of restricted gestational weight gain by dietary intervention on fetal growth in women with gestational diabetes mellitus Lise L. KurtzhalsSidse K. NørgaardElisabeth Reinhardt Mathiesen Article 25 September 2018 Pages: 2528 - 2538
The impact of maternal gestational weight gain on cardiometabolic risk factors in children Claudia H. T. TamRonald C. W. MaWing Hung Tam Article Open access 17 September 2018 Pages: 2539 - 2548
Circulating prolactin concentrations and risk of type 2 diabetes in US women Jun LiMegan S. RiceShelley S. Tworoger Article 11 October 2018 Pages: 2549 - 2560
Which is more important for cardiometabolic health: sedentary time, higher intensity physical activity or cardiorespiratory fitness? The Maastricht Study Jeroen H. P. M. van der VeldeNicolaas C. SchaperAnnemarie Koster Article Open access 10 September 2018 Pages: 2561 - 2569
Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study Ian J. NeelandShruti SinghPhilipp E. Scherer Article 29 August 2018 Pages: 2570 - 2579
Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes Maija FeodoroffValma Harjutsaloon behalf of the FinnDiane Study Group Article 18 September 2018 Pages: 2580 - 2589
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study Thenmalar VadivelooWilliam Jeffcoateon behalf of the Scottish Diabetes Research Network Epidemiology Group Article Open access 31 August 2018 Pages: 2590 - 2597
Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging Gary W. ClineMika NaganawaRoberto A. Calle Article 02 May 2018 Pages: 2598 - 2607
Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice Takao NammoHaruhide UdagawaKazuki Yasuda Article 03 October 2018 Pages: 2608 - 2620
Silencing of high-affinity insulin-reactive B lymphocytes by anergy and impact of the NOD genetic background in mice Mia J. SmithRochelle M. HinmanJohn C. Cambier Article 25 September 2018 Pages: 2621 - 2632
Impact of daily incremental change in environmental temperature on beta cell function and the risk of gestational diabetes in pregnant women Ravi RetnakaranChang YeBernard Zinman Article 15 August 2018 Pages: 2633 - 2642
Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study Mathilde FratyGilberto Velhofor the SURDIAGENE Study Group Article 19 September 2018 Pages: 2643 - 2653
Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine Rosemary E. McDowellPeter BarabasTim M. Curtis Article Open access 15 August 2018 Pages: 2654 - 2667
Probiotic intervention in infancy is not associated with development of beta cell autoimmunity and type 1 diabetes Erkki SavilahtiTaina HärkönenMikael Knip Research Letter 20 September 2018 Pages: 2668 - 2670
Clinical and scientific value in the pursuit of quantification of beta cells in the pancreas by PET imaging Gary W. ClineTimothy J. McCarthyRoberto A. Calle Letter 22 August 2018 Pages: 2671 - 2673
Correction to: Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance Laura FormentiniAlexander J. RyanRobert R. Henry Correction 15 October 2018 Pages: 2674 - 2674